These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22913803)

  • 1. Economic effects of interventions to reduce obesity in Israel.
    Ginsberg GM; Rosenberg E
    Isr J Health Policy Res; 2012 Apr; 1(1):17. PubMed ID: 22913803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis.
    Ginsberg GM; Eidelman AI; Shinwell E; Anis E; Peyser R; Lotan Y
    Isr J Health Policy Res; 2013 Feb; 2(1):6. PubMed ID: 23425020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cost-effectiveness of interventions for obesity: A mendelian randomisation study.
    Harrison S; Dixon P; Jones HE; Davies AR; Howe LD; Davies NM
    PLoS Med; 2021 Aug; 18(8):e1003725. PubMed ID: 34449774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.
    Robertson W; Fleming J; Kamal A; Hamborg T; Khan KA; Griffiths F; Stewart-Brown S; Stallard N; Petrou S; Simkiss D; Harrison E; Kim SW; Thorogood M
    Health Technol Assess; 2017 Jan; 21(1):1-180. PubMed ID: 28059054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counting the lifetime cost of obesity: Analysis based on national England data.
    Heald A; Stedman M; Fryer AA; Davies MB; Rutter MK; Gibson JM; Whyte M
    Diabetes Obes Metab; 2024 Apr; 26(4):1464-1478. PubMed ID: 38312024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel.
    Ginsberg GM
    Isr J Health Policy Res; 2017; 6():1. PubMed ID: 28096974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of lifestyle interventions to treat overweight or obesity in children.
    Hollingworth W; Hawkins J; Lawlor DA; Brown M; Marsh T; Kipping RR
    Int J Obes (Lond); 2012 Apr; 36(4):559-66. PubMed ID: 22249222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology and economic burden of hip fractures in Israel.
    Barnea R; Weiss Y; Abadi-Korek I; Shemer J
    Isr J Health Policy Res; 2018 Aug; 7(1):38. PubMed ID: 30068383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Total Knee Arthroplasty vs Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super-Obese Patients: A Markov Model.
    Ponnusamy KE; Vasarhelyi EM; Somerville L; McCalden RW; Marsh JD
    J Arthroplasty; 2018 Jul; 33(7S):S32-S38. PubMed ID: 29550168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care costs and lost productivity costs related to excess weight in Belgium.
    Gorasso V; Moyersoen I; Van der Heyden J; De Ridder K; Vandevijvere S; Vansteelandt S; De Smedt D; Devleesschauwer B
    BMC Public Health; 2022 Sep; 22(1):1693. PubMed ID: 36068519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of obesity on cost per quality-adjusted life years gained following anterior cervical discectomy and fusion in elective degenerative pathology.
    Chotai S; Sielatycki JA; Parker SL; Sivaganesan A; Kay HL; Stonko DP; Wick JB; McGirt MJ; Devin CJ
    Spine J; 2016 Nov; 16(11):1342-1350. PubMed ID: 27394664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial).
    Panca M; Christie D; Cole TJ; Costa S; Gregson J; Holt R; Hudson LD; Kessel AS; Kinra S; Mathiot A; Nazareth I; Wataranan J; Wong ICK; Viner RM; Morris S
    BMJ Open; 2018 Feb; 8(2):e018640. PubMed ID: 29449292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
    Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
    J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases.
    van Baal PH; van den Berg M; Hoogenveen RT; Vijgen SM; Engelfriet PM
    Value Health; 2008 Dec; 11(7):1033-40. PubMed ID: 18494748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysis.
    Yosefy C; Ginsberg GM; Dicker D; Viskoper JR; Tulchinsky TH; Leibovitz E; Gavish D;
    Blood Press; 2003; 12(4):225-31. PubMed ID: 14596359
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.